These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11799528)

  • 1. Immunotherapy to reconstitute immunity to DNA viruses.
    Gahn B; Hunt G; Rooney CM; Heslop HE
    Semin Hematol; 2002 Jan; 39(1):41-7. PubMed ID: 11799528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive cellular immunotherapy for viral diseases.
    Fujita Y; Rooney CM; Heslop HE
    Bone Marrow Transplant; 2008 Jan; 41(2):193-8. PubMed ID: 17982497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
    Tzannou I; Papadopoulou A; Naik S; Leung K; Martinez CA; Ramos CA; Carrum G; Sasa G; Lulla P; Watanabe A; Kuvalekar M; Gee AP; Wu MF; Liu H; Grilley BJ; Krance RA; Gottschalk S; Brenner MK; Rooney CM; Heslop HE; Leen AM; Omer B
    J Clin Oncol; 2017 Nov; 35(31):3547-3557. PubMed ID: 28783452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Ma CK; Blyth E; Clancy L; Simms R; Burgess J; Brown R; Deo S; Micklethwaite KP; Gottlieb DJ
    Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A registry of HLA-typed donors for production of virus-specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune-compromised patients.
    Li Pira G; Ivaldi F; Starc N; Landi F; Rutella S; Locatelli F; Sacchi N; Tripodi G; Manca F
    Transfusion; 2014 Dec; 54(12):3145-54. PubMed ID: 25041366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive immunotherapy with virus-specific T cells.
    Fuji S; Kapp M; Grigoleit GU; Einsele H
    Best Pract Res Clin Haematol; 2011 Sep; 24(3):413-9. PubMed ID: 21925094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid salvage treatment with virus-specific T cells for therapy-resistant disease.
    Uhlin M; Gertow J; Uzunel M; Okas M; Berglund S; Watz E; Brune M; Ljungman P; Maeurer M; Mattsson J
    Clin Infect Dis; 2012 Oct; 55(8):1064-73. PubMed ID: 22806594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.
    Sukdolak C; Tischer S; Dieks D; Figueiredo C; Goudeva L; Heuft HG; Verboom M; Immenschuh S; Heim A; Borchers S; Mischak-Weissinger E; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1480-92. PubMed ID: 23891747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
    Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
    Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy.
    Fujita Y; Leen AM; Sun J; Nakazawa Y; Yvon E; Heslop HE; Brenner MK; Rooney CM
    J Immunother; 2008 Sep; 31(7):665-74. PubMed ID: 18600178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant.
    Sutrave G; Blyth E; Gottlieb DJ
    Cytotherapy; 2017 Nov; 19(11):1284-1301. PubMed ID: 28927824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive immunotherapy for posttransplantation viral infections.
    Bollard CM; Kuehnle I; Leen A; Rooney CM; Heslop HE
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):143-55. PubMed ID: 14993880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation.
    Ottaviano G; Chiesa R; Feuchtinger T; Vickers MA; Dickinson A; Gennery AR; Veys P; Todryk S
    Cells; 2019 Jan; 8(1):. PubMed ID: 30646564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y; Aïssi-Rothe L; Virion JM; De Carvalho Bittencourt M; Ulas N; Audonnet S; Salmon A; Clement L; Venard V; Jeulin H; Stoltz JF; Decot V; Bensoussan D
    Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for Epstein-Barr virus-associated tumors.
    Comito MA; Sun Q; Lucas KG
    Leuk Lymphoma; 2004 Oct; 45(10):1981-7. PubMed ID: 15370241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD123 redirected multiple virus-specific T cells for acute myeloid leukemia.
    Zhou L; Liu X; Wang X; Sun Z; Song XT
    Leuk Res; 2016 Feb; 41():76-84. PubMed ID: 26740053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy.
    Spielmann G; Bollard CM; Kunz H; Hanley PJ; Simpson RJ
    Sci Rep; 2016 May; 6():25852. PubMed ID: 27181409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.
    Neuenhahn M; Albrecht J; Odendahl M; Schlott F; Dössinger G; Schiemann M; Lakshmipathi S; Martin K; Bunjes D; Harsdorf S; Weissinger EM; Menzel H; Verbeek M; Uharek L; Kröger N; Wagner E; Kobbe G; Schroeder T; Schmitt M; Held G; Herr W; Germeroth L; Bonig H; Tonn T; Einsele H; Busch DH; Grigoleit GU
    Leukemia; 2017 Oct; 31(10):2161-2171. PubMed ID: 28090089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy.
    Foster AE; Gottlieb DJ; Marangolo M; Bartlett A; Li YC; Barton GW; Romagnoli JA; Bradstock KF
    J Hematother Stem Cell Res; 2003 Feb; 12(1):93-105. PubMed ID: 12662440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.